CCK-8 and CCK-58 differ in their effects on nocturnal solid meal pattern in undisturbed rats

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 303, Issue 8, 2012, Pages

  Goebel Stengel, Miriam ^a,b   Stengel, Andreas ^a,b   Wang, Lixin ^a,b   Ohning, Gordon ^a,b   Taché, Yvette ^a,b   Reeve, Joseph R ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Brentwood Biomedical Research Institute Los Angeles   (United States)

Author keywords

Dark phase; Meal microstructure; Satiation; Satiety; Satiety ratio; Solid food

Indexed keywords

CHOLECYSTOKININ 58; CHOLECYSTOKININ DERIVATIVE; CHOLECYSTOKININ OCTAPEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOMATION; CLINICAL ASSESSMENT; CONTROLLED STUDY; DATA ANALYSIS; FEEDING BEHAVIOR; FOOD INTAKE; IN VIVO STUDY; LOCOMOTION; MALE; MEAL; MEDICAL RECORD; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; RAT;

ANIMALS; CHOLECYSTOKININ; CIRCADIAN RHYTHM; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; FEEDING BEHAVIOR; GROOMING; INJECTIONS, INTRAPERITONEAL; MALE; MOTOR ACTIVITY; PHOTOPERIOD; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; SATIETY RESPONSE; SINCALIDE; TIME FACTORS;

EID: 84867693343     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00365.2011     Document Type: Article

References (62)

1. Antin J, Gibbs J, Holt J, Young RC, Smith GP. Cholecystokinin elicits the complete behavioral sequence of satiety in rats. J Comp Physiol Psychol 89: 784-790, 1975.
2. Barrachina MD, Martinez V, Wang L, Wei JY, Taché Y. Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice. Proc Natl Acad Sci USA 94: 10455-10460, 1997.
3. Bayliss WM, Starling EH. The mechanism of pancreatic secretion. J Physiol 28: 325-353, 1902.
4. Brand SJ, Morgan RG. The release of rat intestinal cholecystokinin after oral trypsin inhibitor measured by bio-assay. J Physiol 319: 325-343, 1981.
5. Burton-Freeman B, Gietzen DW, Schneeman BO. Cholecystokinin and serotonin receptors in the regulation of fat-induced satiety in rats. Am J Physiol Regul Integr Comp Physiol 276: R429-R434, 1999.
6. Cox JE, McCown SM, Bridges JM, Tyler WJ. Inhibition of sucrose intake by continuous celiac, superior mesenteric, and intravenous CCK-8 infusions. Am J Physiol Regul Integr Comp Physiol 270: R319-R325, 1996.
7. Criddle DN, Booth DM, Mukherjee R, McLaughlin E, Green GM, Sutton R, Petersen OH, Reeve JR Jr. Cholecystokinin-58 and chole-cystokinin-8 exhibit similar actions on calcium signaling, zymogen secretion, and cell fate in murine pancreatic acinar cells. Am J Physiol Gastrointest Liver Physiol 297: G1085-G1092, 2009.
8. Eberlein GA, Eysselein VE, Goebell H. Cholecystokinin-58 is the major molecular form in man, dog and cat but not in pig, beef and rat intestine. Peptides 9: 993-998, 1988.
9. Eberlein GA, Eysselein VE, Hesse WH, Goebell H, Schaefer M, Reeve JR Jr. Detection of cholecystokinin-58 in human blood by inhibition of degradation. Am J Physiol Gastrointest Liver Physiol 253: G477-G482, 1987.
10. Eckel LA, Ossenkopp KP. Cholecystokinin reduces sucrose palatability in rats: evidence in support of a satiety effect. Am J Physiol Regul Integr Comp Physiol 267: R1496-R1502, 1994.
11. Eng J, Du BH, Pan YC, Chang M, Hulmes JD, Yalow RS. Purification and sequencing of a rat intestinal 22 amino acid C-terminal CCK fragment. Peptides 5: 1203-1206, 1984.
12. Ervin GN, Teeter MN. Cholecystokinin octapeptide and lithium produce different effects on feeding and taste aversion learning. Physiol Behav 36: 507-512, 1986.
13. Eysselein VE, Eberlein GA, Hesse WH, Singer MV, Goebell H, Reeve JR Jr. Cholecystokinin-58 is the major circulating form of cholecysto-kinin in canine blood. J Biol Chem 262: 214-217, 1987.
14. Eysselein VE, Eberlein GA, Schaeffer M, Grandt D, Goebell H, Niebel W, Rosenquist GL, Meyer HE, Reeve JR Jr. Characterization of the major form of cholecystokinin in human intestine: CCK-58. Am J Physiol Gastrointest Liver Physiol 258: G253-G260, 1990.
15. Farley C, Cook JA, Spar BD, Austin TM, Kowalski TJ. Meal pattern analysis of diet-induced obesity in susceptible and resistant rats. Obes Res 11: 845-851, 2003.
16. Folsch UR, Cantor P, Wilms HM, Schafmayer A, Becker HD, Creutzfeldt W. Role of cholecystokinin in the negative feedback control of pancreatic enzyme secretion in conscious rats. Gastroenterology 92: 449-458, 1987.
17. Garlicki J, Konturek PK, Majka J, Kwiecien N, Konturek SJ. Cho-lecystokinin receptors and vagal nerves in control of food intake in rats. Am J Physiol Endocrinol Metab 258: E40-E45, 1990.
18. Geary N. A new way of looking at eating. Am J Physiol Regul Integr Comp Physiol 288: R1444-R1446, 2005.
19. Gibbs J, Young RC, Smith GP. Cholecystokinin decreases food intake in rats. J Comp Physiol Psychol 84: 488-495, 1973.
20. Glatzle J, Raybould HE, Kueper MA, Reeve JR Jr, Zittel TT. Chole-cystokinin-58 is more potent in inhibiting food intake than cholecysto-kinin-8 in rats. Nutr Neurosci 11: 69-74, 2008.
21. Goebel M, Stengel A, Wang L, Taché Y. Central nesfatin-1 reduces the nocturnal food intake in mice by reducing meal size and increasing inter-meal intervals. Peptides 32: 36-43, 2011.
22. Gourcerol G, Million M, Adelson DW, Wang Y, Wang L, Rivier J, St-Pierre DH, Taché Y. Lack of interaction between peripheral injection of CCK and obestatin in the regulation of gastric satiety signaling in rodents. Peptides 27: 2811-2819, 2006.
23. Green GM, Taguchi S, Friestman J, Chey WY, Liddle RA. Plasma secretin, CCK, and pancreatic secretion in response to dietary fat in the rat. Am J Physiol Gastrointest Liver Physiol 256: G1016-G1021, 1989.
24. Harper AA, Raper HS. Pancreozymin, a stimulant of the secretion of pancreatic enzymes in extracts of the small intestine. J Physiol 102: 115-125, 1943.
25. Hoffmann P, Eberlein GA, Reeve JR Jr, Bunte RH, Grandt D, Goebell H, Eysselein VE. Comparison of clearance and metabolism of infused cholecystokinins 8 and 58 in dogs. Gastroenterology 105: 1732-1736, 1993.
26. Huttner WB. Tyrosine sulfation and the secretory pathway. Annu Rev Physiol 50: 363-376, 1988.
27. Ivy AC, Oldenberg E. A hormone mechanism for gall bladder contraction. Am J Physiol 86: 599-613, 1928.
28. Izzo RS, Brugge WR, Praissman M. Immunoreactive cholecystokinin in human and rat plasma: correlation of pancreatic secretion in response to CCK. Regul Pept 9: 21-34, 1984.
29. Jorpes E, Mutt V. Cholecystokinin and pancreozymin, one single hormone? Acta Physiol Scand 66: 196-202, 1966.
30. Kobelt P, Tebbe JJ, Tjandra I, Stengel A, Bae HG, Andresen V, van der Voort IR, Veh RW, Werner CR, Klapp BF, Wiedenmann B, Wang L, Taché Y, Mönnikes H. CCK inhibits the orexigenic effect of peripheral ghrelin. Am J Physiol Regul Integr Comp Physiol 288: R751-R758, 2005.
31. Kowalski TJ, Farley C, Cohen-Williams ME, Varty G, Spar BD. Melanin-concentrating hormone-1 receptor antagonism decreases feeding by reducing meal size. Eur J Pharmacol 497: 41-47, 2004.
32. Larsen CJ, Washington MC, Sayegh AI. Cholecystokinin-8 increases the satiety ratio in diabetic rats more than cholecystokinin-33. Physiol Behav 101: 649-652, 2010.
33. Lateef DM, Washington MC, Sayegh AI. The short-term satiety peptide cholecystokinin reduces meal size and prolongs intermeal interval. Pep-tides 21: 1289-1295, 2011.
34. Liddle RA, Goldfine ID, Williams JA. Bioassay of plasma cholecysto-kinin in rats: effects of food, trypsin inhibitor, and alcohol. Gastroenterology 87: 542-549, 1984.
35. Linden A, Carlquist M, Hansen S, Uvnas-Moberg K. Plasma concentrations of cholecystokinin, CCK-8, and CCK-33, 39 in rats, determined by a method based on enzyme digestion of gastrin before HPLC and RIA detection of CCK. Gut 30: 213-222, 1989.
36. Melville LD, Smith GP, Gibbs J. Devazepide antagonizes the inhibitory effect of cholecystokinin on intake in sham-feeding rats. Pharmacol Biochem Behav 43: 975-977, 1992.
37. Moran TH, Baldessarini AR, Salorio CF, Lowery T, Schwartz GJ. Vagal afferent and efferent contributions to the inhibition of food intake by cholecystokinin. Am J Physiol Regul Integr Comp Physiol 272: R1245- R1251, 1997.
38. Mutt V, Jorpes JE. Structure of porcine cholecystokinin-pancreozymin. 1. Cleavage with thrombin and with trypsin. Eur J Biochem 6: 156-162, 1968.
39. Ogilvie KM, Saladin R, Nagy TR, Urcan MS, Heyman RA, Leibowitz MD. Activation of the retinoid X receptor suppresses appetite in the rat. Endocrinology 145: 565-573, 2004.
40. Polak JM, Bloom SR, Rayford PL, Pearse AG, Buchan AM, Thompson JC. Identification of cholecystokinin-secreting cells. Lancet 2: 1016-1018, 1975.
41. Reeve JR Jr, Eysselein V, Eberlein GA, Chew P, Ho FJ, Huebner VD, Shively JE, Lee TD, Liddle RA. Characterization of canine intestinal cholecystokinin-58 lacking its carboxyl-terminal nonapeptide Evidence for similar post-translational processing in brain and gut. J Biol Chem 266: 13770-13776, 1991.
42. Reeve JR Jr, Green GM, Chew P, Eysselein VE, Keire DA. CCK-58 is the only detectable endocrine form of cholecystokinin in rat. Am J Physiol Gastrointest Liver Physiol 285: G255-G265, 2003.
43. Reeve JR Jr, Keire DA, Coskun T, Green GM, Evans C, Ho FJ, Lee TD, Davis MT, Shively JE, and Solomon TE. Synthesis of biologically active canine CCK-58. Regul Pept 113: 71-77, 2003.
44. Reeve JR Jr, Liddle RA, McVey DC, Vigna SR, Solomon TE, Keire DA, Rosenquist G, Shively JE, Lee TD, Chew P, Green GM, Coskun T. Identification of nonsulfated cholecystokinin-58 in canine intestinal extracts and its biological properties. Am J Physiol Gastrointest Liver Physiol 287: G326-G333, 2004.
45. Reeve JR Jr, McVey DC, Bunnett NW, Solomon TE, Keire DA, Ho FJ, Davis MT, Lee TD, Shively JE, Vigna SR. Differences in receptor binding and stability to enzymatic digestion between CCK-8 and CCK-58. Pancreas 25: e50-e55, 2002.
46. Reeve JR Jr, Wu SV, Keire DA, Faull K, Chew P, Solomon TE, Green GM, Coskun T. Differential bile-pancreatic secretory effects of CCK-58 and CCK-8. Am J Physiol Gastrointest Liver Physiol 286: G395-G402, 2004.
47. Rehfeld JF, Sun G, Christensen T, Hillingso JG. The predominant cholecystokinin in human plasma and intestine is cholecystokinin-33. J Clin Endocrinol Metab 86: 251-258, 2001.
48. Rosenwasser AM, Boulos Z, Terman M. Circadian organization of food intake and meal patterns in the rat. Physiol Behav 27: 33-39, 1981.
49. Roth JD, Coffey T, Jodka CM, Maier H, Athanacio JR, Mack CM, Weyer C, Parkes DG. Combination therapy with amylin and peptide YY[3-36] in obese rodents: anorexigenic synergy and weight loss additivity. Endocrinology 148: 6054-6061, 2007.
50. Stengel A, Coskun T, Goebel M, Wang L, Craft L, Alsina-Fernandez J, Rivier J, Taché Y. Central injection of the stable somatostatin analog ODT8-SST induces a somatostatin2 receptor-mediated orexigenic effect: role of neuropeptide Y and opioid signaling pathways in rats. Endocrinology 151: 4224-4235, 2010.
51. Stengel A, Goebel M, Wang L, Rivier J, Kobelt P, Mönnikes H, Lambrecht NW, Taché Y. Central nesfatin-1 reduces dark-phase food intake and gastric emptying in rats: differential role of corticotropin-releasing factor2 receptor. Endocrinology 150: 4911-4919, 2009.
52. Stengel A, Goebel M, Wang L, Rivier J, Kobelt P, Mönnikes H, Taché Y. Activation of brain somatostatin 2 receptors stimulates feeding in mice: Analysis of food intake microstructure. Physiol Behav 101: 614-622, 2010.
53. Stengel A, Goebel M, Wang L, Rivier J, Kobelt P, Mönnikes H, Taché Y. Selective central activation of somatostatin receptor 2 increases food intake, grooming behavior and rectal temperature in rats. J Physiol Pharmacol 61: 399-407, 2010.
54. Stengel A, Keire D, Goebel M, Evilevitch L, Wiggins B, Taché Y, Reeve JR Jr. The RAPID method for blood processing yields new insight in plasma concentrations and molecular forms of circulating gut peptides. Endocrinology 150: 5113-5118, 2009.
55. Sullivan CN, Raboin SJ, Gulley S, Sinzobahamvya NT, Green GM, Reeve JR Jr, Sayegh AI. Endogenous cholecystokinin reduces food intake and increases Fos-like immunoreactivity in the dorsal vagal complex but not in the myenteric plexus by CCK1 receptor in the adult rat. Am J Physiol Regul Integr Comp Physiol 292: R1071-R1080, 2007.
56. Weatherford SC, Laughton WB, Salabarria J, Danho W, Tilley JW, Netterville LA, Schwartz GJ, Moran TH. CCK satiety is differentially mediated by high- and low-affinity CCK receptors in mice and rats. Am J Physiol Regul Integr Comp Physiol 264: R244-R249, 1993.
57. West DB, Greenwood MR, Marshall KA, Woods SC. Lithium chloride, cholecystokinin and meal patterns: evidence that cholecystokinin suppresses meal size in rats without causing malaise. Appetite 8: 221-227, 1987.
58. West DB, Greenwood MR, Sullivan AC, Prescod L, Marzullo LR, Triscari J. Infusion of cholecystokinin between meals into free-feeding rats fails to prolong the intermeal interval. Physiol Behav 39: 111-115, 1987.
59. Woltman T, Castellanos D, Reidelberger R. Role of cholecystokinin in the anorexia produced by duodenal delivery of oleic acid in rats. Am J Physiol Regul Integr Comp Physiol 269: R1420-R1433, 1995.
60. Wu SV, Harikumar KG, Burgess RJ, Reeve JR Jr, Miller LJ. Effects of cholecystokinin-58 on type 1 cholecystokinin receptor function and regulation. Am J Physiol Gastrointest Liver Physiol 295: G641-G647, 2008.
61. Yamamoto M, Reeve JR Jr, Green GM. Supramaximal CCK-58 does not induce pancreatitis in the rat: role of pancreatic water secretion. Am J Physiol Gastrointest Liver Physiol 292: G964-G974, 2007.
62. Yamamoto M, Reeve JR Jr, Keire DA, Green GM. Water and enzyme secretion are tightly coupled in pancreatic secretion stimulated by food or CCK-58 but not by CCK-8. Am J Physiol Gastrointest Liver Physiol 288: G866-G879, 2005.